bisoprolol has been researched along with Marfan Syndrome, Type I in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jondeau, G | 1 |
| Barthelet, M | 1 |
| Baumann, C | 1 |
| Bonnet, D | 1 |
| Chevallier, B | 1 |
| Collignon, P | 1 |
| Dulac, Y | 1 |
| Edouard, T | 1 |
| Faivre, L | 1 |
| Germain, D | 1 |
| Khau Van Kien, P | 1 |
| Lacombe, D | 1 |
| Ladouceur, M | 1 |
| Lemerrer, M | 1 |
| Leheup, B | 1 |
| Lupoglazoff, JM | 1 |
| Magnier, S | 1 |
| Muti, C | 1 |
| Plauchu, PH | 1 |
| Raffestin, B | 1 |
| Sassolas, F | 1 |
| Schleich, JM | 1 |
| Sidi, D | 1 |
| Themar-Noël, C | 1 |
| Varin, J | 1 |
| Wolf, JE | 1 |
1 other study available for bisoprolol and Marfan Syndrome, Type I
| Article | Year |
|---|---|
[Recommendations for the medical management of aortic complications of Marfan's syndrome].
Topics: Adrenergic beta-Antagonists; Aortic Aneurysm; Aortic Dissection; Atenolol; Bisoprolol; Calcium Chann | 2006 |